Physician profile
Danielle Anderson
NPI 1457991168
$912.59
in general payments reported to CMS, 2019-2025
13 companies · $35.72 in 2025
The $35.72 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $147 · 2022: $241 · 2023: $300 · 2024: $189 · 2025: $35.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $524.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $391.33 | 2022-2025 | |
| Lilly USA, LLC | $170.86 | 2021-2023 | Mounjaro |
| Novo Nordisk INC | $95.15 | 2021-2024 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $52.12 | 2021-2022 | |
| Glaxosmithkline, LLC. | $49.01 | 2021-2023 | Shingrix, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $31.49 | 2024-2025 | Farxiga |
| Amgen INC. | $28.16 | 2021-2023 | Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $18.81 | 2022 | |
| Dexcom, INC. | $18.65 | 2022 | |
| Idorsia Pharmaceuticals US INC | $16.53 | 2023 | Quviviq |
| Exact Sciences Corporation | $15.40 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $12.64 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $12.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.